Women’s Infertility Therapeutics – Pipeline Assessment and Market Forecasts to 2018

Summary

TOTAL S.A. (TOTAL) completed the sale of its 48.83% stake in Compania Espanola de Petroleos, S.A. (CEPSA) to International Petroleum Investment Company (IPIC), an investment company, for a consideration of approximately €3,700m ($4,997.29m). Following the acquisition, IPIC holds around 96% stake and is expected to bid for the remaining stake for €28 per share ($37.82 per share). The acquisition enables IPIC to strengthen its presence in Europe.

Scope

– Rationale behind IPIC acquiring increased stake in CEPSA
– Strategic benefits for the companies involved,
– Geography covered -Europe

Reasons to buy

– Develop a sound understanding of the major M&As, Partnerships, and Joint Ventures taking place in European oil and gas industry,
– Identify the most lucrative segments to leverage on the growth oppurtunities available in the Spains oil & gas market,
– Get a detailed analysis of a deal to enable you to take better decisions.

1.1 List of Tables 4
1.2 List of Figures 5
2 Women’s Infertility Therapeutics – Introduction 6
2.1 Overview 6
2.1.1 Quality of Life 7
2.2 Epidemiology 7
2.3 Etiology and Pathophysiology 7
2.4 Signs and Symptoms 9
2.5 Diagnosis 9
2.6 Treatment and Management 10
2.7 GlobalData Pipeline Report Guidance 12
3 Women’s Infertility Therapeutics – Market Characterization 13
3.1 Overview 13
3.2 Women’s Infertility Therapeutics Market Size (2005-2010) – Global 13
3.3 Women’s Infertility Therapeutics Market Forecast (2010-2018) – Global 14
3.4 Women’s Infertility Therapeutics Market Size (2005-2010) – The US 15
3.5 Women’s Infertility Therapeutics Market Forecast (2010-2018) – The US 16
3.6 Women’s Infertility Therapeutics Market Size (2005-2010) – France 17
3.7 Women’s Infertility Therapeutics Market Forecast (2010-2018) – France 18
3.8 Women’s Infertility Therapeutics Market Size (2005-2010) – Germany 19
3.9 Women’s Infertility Therapeutics Market Forecast (2010-2018) – Germany 20
3.10 Women’s Infertility Therapeutics Market Size (2005-2010) – Italy 21
3.11 Women’s Infertility Therapeutics Market Forecast (2010-2018) – Italy 22
3.12 Women’s Infertility Therapeutics Market Size (2005-2010) – Spain 23
3.13 Women’s Infertility Therapeutics Market Forecast (2010-2018) – Spain 24
3.14 Women’s Infertility Therapeutics Market Size (2005-2010) – The UK 25
3.15 Women’s Infertility Therapeutics Market Forecast (2010-2018) – The UK 26
3.16 Women’s Infertility Therapeutics Market Size (2005-2010) – Japan 27
3.17 Women’s Infertility Therapeutics Market Forecast (2010-2018) – Japan 28
3.18 Drivers and Barriers for the Women’s Infertility Therapeutics Market 29
3.18.1 Drivers for the Women’s Infertility Therapeutics Market 29
3.18.2 Barriers for the Women’s Infertility Therapeutics Market 29
3.19 Opportunity and Unmet Need 30
3.20 Key Takeaway 30

For more information, please visit:

http://www.aarkstore.com/reports/Women%E2%80%99s-Infertility-Therapeutics-Pipeline-Assessment-and-Market-Forecasts-to-2018-154412.html

Or email us at contact@aarkstore.com or call +918149852585

Processing your request, Please wait....